• About us
• Contact

Advertisement

Collaboration › Details

MeiraGTx–Chardan: investor conference, 202210 supply service MeiraGTx to participate in Chardan’s Annual Genetic Medicines Conference

 

	Period	2022-09-14
	Partner, 1st	MeiraGTx Holdings Plc (NASDAQ: MGTX)
	Group	MeiraGTx (Group)
	Partner, 2nd	Chardan Capital Markets LLC
	Product	gene therapy
	Person	Forbes, Alexandria (MeiraGTx 201810 CEO)

MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY.

MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences:


> Morgan Stanley 20th Annual Global Healthcare Conference

Fireside Chat: Wednesday, September 14, 2022, at 3:30 p.m. ET


> Chardan's 6th Annual Genetic Medicines Conference

Panel Discussion: “Gene Regulation”, Tuesday, October 4, 2022, at 9:30 a.m. ET

Fireside Chat: Tuesday, October 4, 2022, at 10:30 a.m. ET


A live webcast of the fireside chats will be available on the Investors page of the Company’s website at www.investors.meiragtx.com. Replays will be available for approximately 30 days following the presentation dates.

Record changed: 2022-09-10

Advertisement

More documents for MeiraGTx (Group)

• [1] MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY....
• [2] MeiraGTx Holdings plc. (11/19/20). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY....
• [3] MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY....
• [4] MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY....
• [5] MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY....
• [6] MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY....
• [7] MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency". London & New York, NY....
• [8] MeiraGTx Holdings plc. (5/10/19). "Press Release: MeiraGTx Appoints Nicole Seligman to Board of Directors". London & New York, NY....
• [9] MeiraGTx Holdings plc. (5/6/19). "Press Release: MeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference". London & New York, NY....
• [10] MeiraGTx Holdings plc. (4/25/19). "Press Release: MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019". London & New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.